These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 1626572
21. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)]. Kitamura K, Asano S, Mizoguchi H, Takaku F. Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327 [Abstract] [Full Text] [Related]
22. Haematopoietic growth factors as supportive therapy in HIV-infected patients. Hermans P. AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801 [Abstract] [Full Text] [Related]
23. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Antin JH, Smith BR, Holmes W, Rosenthal DS. Blood; 1988 Aug; 72(2):705-13. PubMed ID: 3042046 [Abstract] [Full Text] [Related]
24. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A. Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338 [Abstract] [Full Text] [Related]
25. A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Guinan EC, Sieff CA, Oette DH, Nathan DG. Blood; 1990 Sep 15; 76(6):1077-82. PubMed ID: 2205306 [Abstract] [Full Text] [Related]
26. Effect of low-dose granulocyte-macrophage colony-stimulating factor (LD-GM-CSF) on platelet transfusion-dependent thrombocytopenia. Vesole DH, Jagannath S, Glenn LD, Barlogie B. Am J Hematol; 1994 Nov 15; 47(3):203-7. PubMed ID: 7942785 [Abstract] [Full Text] [Related]
27. [Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia]. Asano S, Hirashima K, Yoshida Y, Takaku F, Miyazaki T, Omine M, Furusawa S, Abe T, Mori M, Arimori S. Rinsho Ketsueki; 1990 Sep 15; 31(9):1456-62. PubMed ID: 1701008 [Abstract] [Full Text] [Related]
30. [Sustained long-term complete remission in an elderly aplastic anemia patient after cessation of combined therapy consisting of granulocyte-colony stimulating factor and erythropoietin]. Yasuyama M, Kawauchi K, Sugiyama H, Ohkawa S. Rinsho Ketsueki; 2000 Jan 15; 41(1):42-7. PubMed ID: 10695398 [Abstract] [Full Text] [Related]
31. Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial. Kritz A, Crown JP, Motzer RJ, Reich LM, Heller G, Moore MP, Hamilton N, Yao TJ, Heelan RT, Schneider JG. Cancer; 1993 Apr 15; 71(8):2515-21. PubMed ID: 8095854 [Abstract] [Full Text] [Related]
34. An open phase I study to assess the biological effects of a continuous intravenous infusion of Interleukin-3 followed by Granulocyte Macrophage-Colony Stimulating Factor. Bretti S, Gilleece MH, Kamthan A, Fitzsimmons L, Hicks F, Rowlands M, Bishop P, Picardo AM, Dexter TM, Scarffe JH. Eur J Cancer; 1996 Jun 15; 32A(7):1171-8. PubMed ID: 8758249 [Abstract] [Full Text] [Related]